| # | Drug | Count |
|---|---|---|
| 0 | MINOCYCLINE | 16 |
| 1 | BISOPROLOL FUMARATE | 13 |
| 2 | FUROSEMIDE | 11 |
| 3 | RAMIPRIL | 11 |
| 4 | WARFARIN | 11 |
| 5 | ADALIMUMAB | 7 |
| 6 | NIVOLUMAB | 7 |
| 7 | CARBOPLATIN | 6 |
| 8 | IPILIMUMAB | 6 |
| 9 | METFORMIN | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MINOCYCLINE | 16 | 0.0014 |
| 1 | EMPAGLIFLOZIN AND LINAGLIPTIN | 2 | 0.0010 |
| 2 | ASENAPINE MALEATE | 5 | 0.0006 |
| 3 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 4 | DUTASTERIDE | 3 | 0.0004 |
| 5 | DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE | 1 | 0.0003 |
| 6 | IODIXANOL | 1 | 0.0003 |
| 7 | VERAPAMIL HYDROCHLORIDE | 1 | 0.0002 |
| 8 | LINAGLIPTIN | 3 | 0.0002 |
| 9 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 5 | 0.0002 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 6 | 0.0001 |
| 2 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 3 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 5 | Barbiturate [EPC] | 1 | 0.0001 |
| 6 | Angiotensin Converting Enzyme Inhibitor [EPC] | 11 | 0.0001 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 7 | 0.0001 |
| 9 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |